SSG
NVS icon

Summit Securities Group’s Novartis NVS Stock Holding History

Summit Securities Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600
Closed -$91.7K – 1311
2026
Q1 		$91.7K Buy
+600
New +$92K 0.01% 299
2025
Q4 		– Sell
-2,365
Closed -$303K – 1177
2025
Q3 		$303K Buy
2,365
+1,833
+345% +$224K 0.06% 220
2025
Q2 		$64.4K Buy
532
+332
+166% +$37.4K 0.01% 452
2025
Q1 		$22.3K Buy
+200
New +$21.3K ﹤0.01% 451
2024
Q1 		– Sell
-50,851
Closed -$5.13M – 765
2023
Q4 		$5.13M Buy
+50,851
New +$4.91M 0.46% 37
2023
Q3 		– Sell
-4,523
Closed -$455K – 891
2023
Q2 		$455K Buy
4,523
+4,522
+452,200% +$452K 0.06% 151
2023
Q1 		$0 Sell
1
-2,096
-100% -$183K ﹤0.01% 1138
2022
Q4 		$190K Buy
+2,097
New +$177K 0.01% 490
2022
Q2 		– Sell
-1
Closed – – 1150
2022
Q1 		$0 Buy
+1
New +$87 ﹤0.01% 1274
2019
Q2 		– Sell
-6,138
Closed -$529K – 376
2019
Q1 		$529K Buy
+6,138
New +$493K 0.1% 109
2015
Q3 		– Sell
-1,228
Closed -$108K – 469
2015
Q2 		$108K Buy
1,228
+670
+120% +$61.5K 0.05% 121
2015
Q1 		$49K Buy
558
+335
+150% +$29.7K 0.04% 160
2014
Q4 		$19K Sell
223
-223
-50% -$18.5K 0.01% 404
2014
Q3 		$38K Sell
446
-2,009
-82% -$163K 0.01% 428
2014
Q2 		$199K Sell
2,455
-1,897
-44% -$149K 0.07% 160
2014
Q1 		$332K Buy
4,352
+2,343
+117% +$171K 0.2% 63
2013
Q4 		$145K Sell
2,009
-446
-18% -$31K 0.03% 198
2013
Q3 		$169K Hold
2,455
– – 0.06% 124
2013
Q2 		$156K Buy
+2,455
New +$160K 0.07% 107

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Summit Securities Group's NVS Position: Q2 2026 in Review

Summit Securities Group sold out of Novartis (NVS) in Q2 2026, closing a stake of 600 shares — an estimated $91.7K sold.

Summit Securities Group first reported a position in NVS in Q2 2013 and held it in 19 quarters. The position peaked at $5.13M in Q4 2023. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Summit Securities Group reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 600 Novartis shares in Q2 2026, an estimated $91.7K.
  • Summit Securities Group first reported a position in Novartis in Q2 2013 and held it in 19 quarters.
  • Summit Securities Group's Novartis position peaked at $5.13M in Q4 2023.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.